KINSORDIA Trademark

Trademark Overview


On Tuesday, January 28, 2025, a trademark application was filed for KINSORDIA with the United States Patent and Trademark Office. The USPTO has given the KINSORDIA trademark a serial number of 99020576. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, August 11, 2025. This trademark is owned by Vedanta Biosciences, Inc.. The KINSORDIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals and therapeutic agents for the treatment and prevention of diseases and medical conditions, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; Pharmaceutical and biopharmaceutical agents, namely, microbiologics, immunotherapeutics, live biotherapeutic products and other therapeutic agents for the treatment and prevention of diseases and medical conditions, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; Pharmaceuticals in the nature of cultures of microorganisms for medical use
kinsordia

General Information


Serial Number99020576
Word MarkKINSORDIA
Filing DateTuesday, January 28, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, August 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 2, 2025

Trademark Statements


Goods and ServicesPharmaceuticals and therapeutic agents for the treatment and prevention of diseases and medical conditions, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; Pharmaceutical and biopharmaceutical agents, namely, microbiologics, immunotherapeutics, live biotherapeutic products and other therapeutic agents for the treatment and prevention of diseases and medical conditions, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; Pharmaceuticals in the nature of cultures of microorganisms for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 28, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVedanta Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Tuesday, January 28, 2025NEW APPLICATION ENTERED
Tuesday, January 28, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 8, 2025ASSIGNED TO EXAMINER
Tuesday, January 28, 2025APPLICATION FILING RECEIPT MAILED
Friday, July 11, 2025NON-FINAL ACTION WRITTEN
Friday, July 11, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 24, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 24, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 25, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 28, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 11, 2025NON-FINAL ACTION E-MAILED